Remove Bioequivalency Remove DNA Remove Genetic Disease Remove Protein
article thumbnail

Clinical Catch-Up: December 21-25 | BioSpace

The Pharma Data

The drug is a topical ointment applied to the lower lid to address the build-up and shedding of proteins at the opening of the Meibomian gland. GM2 gangliosidosis is a rare and fatal monogenic lysosomal storage disorder and a family of neurodegenerative genetic diseases that includes Tay-Sachs and Sandhoff diseases.

Trials 52